导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -18.97% | 977/1050 |
| 近一周 | -3.88% | 954/1104 |
| 近一月 | -4.15% | 520/1102 |
| 近一季 | -10.84% | 703/1092 |
| 近半年 | -24.32% | 1027/1070 |
| 近一年 | -13.35% | 783/1018 |
| 近两年 | 21.67% | 759/926 |
| 近三年 | -5.30% | 715/834 |
| 成立以来 | 165.90% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
1.32% 400/1070 |
-16.94% 1044/1101 |
- - |
- - |
| 2025 | 27.15% 529/1065 |
2.05% 644/1014 |
-0.85% 752/1038 |
19.85% 613/1050 |
4.86% 142/1065 |
| 2024 | 4.60% 440/1011 |
-4.09% 539/960 |
-1.22% 390/983 |
14.72% 253/991 |
-3.76% 587/1011 |
| 2023 | -22.90% 742/952 |
-2.75% 742/880 |
-8.74% 721/895 |
-1.52% 137/915 |
-11.78% 896/952 |
| 2022 | -15.59% 192/867 |
-7.98% 67/773 |
4.36% 556/806 |
-11.29% 320/845 |
-0.91% 484/867 |
| 2021 | 15.31% 189/740 |
1.41% 101/580 |
15.62% 224/659 |
-4.56% 334/704 |
3.05% 303/740 |
| 2020 | 82.40% 83/554 |
- 157/419 |
26.83% 164/466 |
18.73% 70/517 |
21.13% 108/554 |
| 2019 | 52.91% 130/410 |
33.41% 201/1149 |
1.93% 173/1231 |
6.02% 181/390 |
6.07% 307/410 |
| 2018 | -19.78% 72/349 |
- - |
- - |
- - |
-9.44% 254/1080 |
| 2017 | 25.37% 61/285 |
- - |
- - |
- - |
- - |
| 2016 | -10.58% 68/205 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8316 | 54.00% |
| 招商前沿医疗保健股票C | 0.7978 | 53.69% |
| 招商医药健康产业股票 | 2.5730 | 48.73% |
| 嘉实医疗保健股票 | 2.5780 | 39.05% |
| 广发医药精选股票A | 1.3132 | 38.48% |
| 广发医药精选股票C | 1.2923 | 38.32% |
| 前海开源公共卫生股票A | 0.4690 | 37.42% |
| 前海开源公共卫生股票C | 0.4590 | 37.30% |
| 交银医药创新股票C | 3.0594 | 35.86% |
| 交银医药创新股票A | 2.8810 | 32.85% |
| 工银美丽城镇股票A VS. 东吴新产业精选股票A(580008) |